Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

As intelligence itself becomes privatised by big tech, allowing your intellectual faculties to wither in service of inane bots seems a dangerous move Long before the age of multi-billion-dollar AI ...

Most AI coding benchmarks still ask the question: did the agent produce code that passes the current tests? This is a useful question, but it is too narrow. Software development is iterative.

As tools like Claude Code get better, more and more developers are happy to hand off coding tasks to them. The way software gets built has changed for good. The vibes were strong at Code with Claude, ...

It’s a weird time to be studying computer science. Recent grads have a higher unemployment rate than those in just about every other major—yes, even philosophy. The internet is littered with rants ...

Salesforce CEO Marc Benioff has said that his software firm expects to spend $300 million on Anthropic tokens this year, almost entirely for coding. Benioff announced his plans during the All-In ...

Illustration by The Atlantic. Sources: Getty. Watching the clips, and then the reactions, and then reading stories about the reactions, and then taking in blog-style, big-idea conclusions about what ...

New York magazine is examining the past work of one of its writers who has been accused of plagiarism after publishing at least three stories with striking similarities to other published work. Ross ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. This as-told-to essay is based on a conversation with Carol Merlo and her son, Kevin Masterson. Merlo ...

Recursion Pharmaceuticals is using AI to improve how we develop drugs. The company has partnered with several major corporations in this quest. The biotech has yet to show meaningful results from its ...